Vein Thrombosis After Splenic and Pancreatic Surgery

Oct 25, 2017 by in ONCOLOGY Comments Off on Vein Thrombosis After Splenic and Pancreatic Surgery

Risk factors Donor Receptor Older 45 years old and cardiovascular disease as cause of death Pancreaticoduodenojejunal anastomosis Asystolia donor Acute failure of graft Unstable haemodynamically Peritoneal dialysis Use of desmopressin…

read more

Thromboembolism in Brain Tumor Patients

Oct 25, 2017 by in ONCOLOGY Comments Off on Thromboembolism in Brain Tumor Patients

Cancer type/Site Diagnoses/100 hospitalizations VTE PE DVT Pancreas 4.3 1.2 3.5 Brain 3.5 1.0 2.8 Myeloproliferative, other lymphatic/hematopoetic 2.9 b 2.5 Stomach 2.7 0.7 2.3 Lymphoma, lymphosarcoma, reticulosarcoma 2.5 0.6…

read more

Therapy in Patients with Chronic Kidney Disease

Oct 25, 2017 by in ONCOLOGY Comments Off on Therapy in Patients with Chronic Kidney Disease

Fig. 1 Mechanism of action of unfractionated heparin, low-molecular-weight heparin, and fondaparinux Only one-third of UFH molecule contain the high-affinity pentasaccharide required for anticoagulant effect [22]. The UFH fraction with…

read more

Prophylaxis for Morbidly Obese Patients Undergoing Bariatric Surgery

Oct 25, 2017 by in ONCOLOGY Comments Off on Prophylaxis for Morbidly Obese Patients Undergoing Bariatric Surgery

© Springer International Publishing Switzerland 2016Md. Shahidul Islam (ed.)Thrombosis and Embolism: from Research to Clinical PracticeAdvances in Experimental Medicine and Biology90610.1007/5584_2016_101 Thromboembolic Prophylaxis for Morbidly Obese Patients Undergoing Bariatric Surgery Jaime Ruiz-Tovar1   and Carolina Llavero2…

read more

Use of Surgical Care Improvement Projects in Prevention of Venous Thromboembolism

Oct 25, 2017 by in ONCOLOGY Comments Off on Use of Surgical Care Improvement Projects in Prevention of Venous Thromboembolism

© Springer International Publishing Switzerland 2016Md. Shahidul Islam (ed.)Thrombosis and Embolism: from Research to Clinical PracticeAdvances in Experimental Medicine and Biology90610.1007/5584_2016_102 The Use of Surgical Care Improvement Projects in Prevention of Venous Thromboembolism…

read more

Therapy by Tissue Plasminogen Activator for Pulmonary Embolism

Oct 25, 2017 by in ONCOLOGY Comments Off on Therapy by Tissue Plasminogen Activator for Pulmonary Embolism

“Absolute” contraindications:  Ongoing bleeding or recent severe bleeding  Known bleeding diseases  Intracranial bleeding or previous intracranial bleeding  Structural intracranial cerebrovascular diseases that increase risk for bleeding (e.g., aneurysm)  Some malignant…

read more
Get Clinical Tree app for offline access